Patanase Approval History
- FDA approved: Yes (First approved April 15th, 2008)
- Brand name: Patanase
- Generic name: olopatadine hydrochloride
- Dosage form: Nasal Spray
- Company: Alcon, Inc.
- Treatment for: Allergic Rhinitis
Patanase (olopatadine) is an antihistamine nasal spray for the treatment of symptoms of seasonal allergic rhinitis in adults and adolescents twelve years of age and older.
Development History and FDA Approval Process for Patanase
|Apr 16, 2008||Alcon's Patanase Nasal Spray Approved by FDA for Treatment of Nasal Allergy Symptoms|
|Oct 11, 2007||Alcon Amends NDA for Patanase Nasal Spray|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.